Posts Tagged ‘Primary Cells’
Scaling Cell & Gene Therapy Development: How CGT Global Supports Research, Clinical Trials, and Commercialization
By Joanna Wirkus, PhD From RUO to cGMP, CGT Global delivers quality, consistency, and regulatory readiness to help researchers advance therapies from discovery to patients. Executive Summary CGT Global accelerates cell and gene therapy development from discovery to commercialization. By providing rapid and reliable access to high-quality RUO and cGMP-certified materials and operating FDA- and CLIA-certified…
For More InformationCryopreservation in Cell and Gene Therapy: Ensuring High-Viability Cells for Research & Manufacturing
By Joanna Wirkus The Role of Cryopreservation in Cell and Gene Therapy Cryopreservation is a cornerstone of cell and gene therapy, enabling the long-term storage and viability of vital cell types such as CD34+ hematopoietic stem cells, mesenchymal stem cells (MSCs), natural killer (NK) cells, and T cells used in CAR-T therapies. Interestingly, nature has…
For More InformationOptimizing Gene and Cell Therapy Research by Starting with Properly Sourced Human Bone Marrow Cells
By: Joanna Wirkus Bone Marrow Cells: Critical Tools Driving Stem Cell and Gene Therapy Innovation Surprisingly safe and well tolerated, the first bone marrow biopsy was performed on the shinbone in 1908 by Italian physician Giovanni Ghedini. Today, bone marrow continues to be an important source of information about the health status of individuals with…
For More Information